Does Tremfya (guselkumab) treat prostate-specific antigen (PSA) problems?
Tremfya is approved to treat plaque psoriasis and psoriatic arthritis, not PSA levels or prostate conditions. There’s no provided information here showing Tremfya is used to lower PSA or treat benign prostatic hyperplasia, prostatitis, or prostate cancer.
Is “PSA” sometimes used to mean psoriatic arthritis?
Yes. Many people searching online for “PSA” actually mean psoriatic arthritis (not prostate-specific antigen). If you mean psoriatic arthritis, Tremfya is used for that condition.
If you meant PSA as prostate-specific antigen, what are typical treatment goals?
For PSA related issues, the goal is usually to diagnose the cause of PSA elevation (for example, infection/inflammation vs. benign causes vs. cancer risk) and manage based on that cause. Tremfya is not indicated for those pathways based on the information provided.
Could Tremfya affect PSA blood test results indirectly?
Tremfya’s indication is for immune-mediated skin and joint disease. Without specific evidence tied to prostate-specific antigen testing or prostate diagnoses, there isn’t enough here to say it would reliably change PSA levels or be used to manage PSA.
Quick clarification to get a precise answer
When you say “PSA,” do you mean:
1) psoriatic arthritis, or
2) prostate-specific antigen (PSA) / prostate issues?
Reply with which one you mean (and your condition if you know it), and I can give a targeted answer.